HALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INC

HALOZYME THERAPEUTICS INC

No trades
See on Supercharts

Price target

863.010.00 0.00%
The 11 analysts offering 1 year price forecasts for HALO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to HALO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

HALO EPS for the last quarter is 13.09 MXN despite the estimation of 11.38 MXN. In the next quarter EPS is expected to reach 12.53 MXN. Track more of HALOZYME THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter HALOZYME THERAPEUTICS INC revenue is expected to reach ‪3.40 B‬ MXN. Check out HALOZYME THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, HALO price target is 863.01 MXN with a max estimate of 1200.38 MXN and a min estimate of 693.18 MXN. Check if this forecast comes true in a year, meanwhile watch HALOZYME THERAPEUTICS INC stock price chart and keep track of the current situation with HALO news and stock market news.
We've gathered opinions of 12 analysts rating HALO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.